Isolation of a NCK-associated Kinase, PRK2, an SH3-binding Protein and Potential Effector of Rho Protein Signaling by Quilliam, Lawrence A. et al.
Isolation of a NCK-associated Kinase, PRK2, an SH3-binding Protein
and Potential Effector of Rho Protein Signaling*
(Received for publication, June 20, 1996, and in revised form, September 16, 1996)
Lawrence A. Quilliam‡§, Que T. Lambert¶, Leigh A. Mickelson-Young‡, John K. Westwick¶i,
Andrew B. Sparks**, Brian K. Kay**‡‡, Nancy A. Jenkins§§, Debra J. Gilbert§§,
Neal G. Copeland§§, and Channing J. Der¶‡‡
From the ‡Department of Biochemistry and Molecular Biology and the Walther Oncology Center, Indiana University
School of Medicine, Indianapolis, Indiana 46202, Departments of ¶Pharmacology and **Biology and the ‡‡Lineberger
Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina 27599, and §§Mammalian
Genetics Laboratory, ABL Basic Research Program, NCI-Frederick Cancer Research and Development Center,
Frederick, Maryland 21702
The NCK adapter protein is comprised of three con-
secutive Src homology 3 (SH3) protein-protein interac-
tion domains and a C-terminal SH2 domain. Although
the association of NCK with activated receptor protein-
tyrosine kinases, via its SH2 domain, implicates NCK as
a mediator of growth factor-induced signal transduc-
tion, little is known about the pathway(s) downstream of
NCK recruitment. To identify potential downstream ef-
fectors of NCK we screened a bacterial expression li-
brary to isolate proteins that bind its SH3 domains. Two
molecules were isolated, the Wiskott-Aldrich syndrome
protein (WASP, a putative CDC42 effector) and a serine/
threonine protein kinase (PRK2, closely related to the
putative Rho effector PKN). Using interspecific back-
cross analysis the Prk2 gene was mapped to mouse chro-
mosome 3. Unlike WASP, which bound the SH3 domains
of several signaling proteins, PRK2 specifically bound to
the middle SH3 domain of NCK and (weakly) that of
phospholipase Cg. PRK2 also specifically bound to Rho
in a GTP-dependent manner and cooperated with Rho
family proteins to induce transcriptional activation via
the serum response factor. These data suggest that
PRK2 may coordinately mediate signal transduction
from activated receptor protein-tyrosine kinases and
Rho and that NCK may function as an adapter to con-
nect receptor-mediated events to Rho protein signaling.
Upon association with ligand, receptor protein-tyrosine ki-
nases (PTKs)1 dimerize and transphosphorylate on tyrosine
residues. These phosphotyrosine-containing sequences then
provide docking sites for SH2 and PTB domains, modular pro-
tein-protein interaction domains that bind to phosphotyrosine
in the context of adjacent C- or N-terminal peptide sequences,
respectively (1). In addition to recruiting signaling enzymes
such as phosphoinositide 3-kinase, phospholipase Cg, and p120
GAP, adapter molecules including Grb2, Crk, and NCK also
bind to PTKs via their SH2 domains. While lacking enzymatic
activities, these adaptor proteins possess SH3 domains that
bind to proline-rich sequences, minimally containing a consen-
sus PXXP motif, in other signaling molecules (1–3). Possibly
the best characterized adapter molecule is Grb2 that binds to
PXXP motifs in the C terminus of the Ras guanine nucleotide
exchange factor, Sos, recruiting it to the plasma membrane
where it promotes Ras activation (4).
The role of the adapter molecule NCK is less clearly under-
stood. NCK is made up of three consecutive SH3 domains and
a C-terminal SH2 domain (5). While the SH2 domain binds to
a number of receptor-PTKs, including the epidermal, platelet-
derived, and vascular endothelial cell growth factor receptors
as well as the insulin receptor substrate, IRS-1 (6–8), little is
known about the putative effector proteins that bind to its
three SH3 domains. NCK’s SH3 domains have been shown to
bind to Cbl (9), a major PTK substrate and possible inhibitor of
cellular signaling (10), as well as Sos1 (11), two molecules that
also associate with Grb2 (12). However, unlike Grb2 (13),2
NCK has also been found to induce cellular transformation
and to coprecipitate with serine/threonine protein kinases (7,
14, 15), suggesting that these adapter proteins have divergent
functions.
To gain further insight into NCK function, we have used
bacterial expression cloning to identify two additional NCK
SH3-binding proteins. One of these proteins is the gene product
of the autosomal recessive immune deficiency Wiskott-Aldrich
syndrome (WASP) (16). The other is a serine-threonine kinase,
PRK2, sharing significant homology to PKN/PRK1, a lipid-
regulated protein kinase recently isolated by virtue of its ho-
mology to protein kinase C (17, 18) and shown to be activated
by the Rho GTPase (19, 20). The interaction of NCK with
WASP, PRK2, and PAK (21),3 three proteins that are all puta-
tive effectors of Rho family GTPases (19–22), suggests that
NCK may play a role in coupling PTK activation to Rho family
signaling. We show here that cotransfection of NIH 3T3 cells
with plasmids encoding PRK2 and Rho family GTPases re-
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sulted in enhancement of Rho-stimulated transcriptional acti-
vation by the c-fos serum response factor. Therefore, PRK2may
be a downstream effector of Rho that mediates its ability to
induce gene expression.
MATERIALS AND METHODS
Plasmid Constructs—Individual NCK SH3 domains (first SH3,
codons 1–68; second SH3, codons 101–166; third SH3, codons 191–257)
plus a second SH3/third SH3 fragment (codons 101–257) were gener-
ated by polymerase chain reaction using the human NCK cDNA (5) as
template and subcloned into pGEX-XL (a pGEX-2T derivative encoding
the A kinase-phosphorylatable RRASV sequence 59 of the BamHI site).
These and other GST-fusion proteins were generated in XL1-blue as
described (3). For expression in mammalian cells, the NCK cDNA was
cloned into the pZIP-NeoSV(x)1 retroviral vector (23) or inserted in
frame with the hemagglutinin epitope tag of the pCGN vector (24).
Library Screening—A lEXlox 16-day mouse embryo cDNA library
(Novagen) was plated (720,000 plaques), and recombinant protein ex-
pression was induced overnight by overlaying 10 mM isopropyl b-D-
thiogalactoside-impregnated nitrocellulose filters. Filters were washed
in Tris-buffered saline, pH 7.4, containing 0.05% Tween 20 and blocked
for ;6 h in 50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 0. 1% Tween 20, 1
mM EDTA, 1 mM dithiothreitol, and 3% bovine serum albumin. The
GST-NCKSH3/SH3 probe was labeled by incubation of 100 ml of bead-
immobilized fusion protein in 20 mM Tris-HCl, 100 mM NaCl, 12 mM
MgCl2, 1 mM dithiothreitol, 4 ml of [g-
32P]ATP (3000 Ci/mmol), and 10
units of heart muscle kinase (Sigma) in a 130-ml total volume. Beads
were extensively washed and labeled protein eluted with 100 mM Tris-
HCl, pH 8.0, 100 mM NaCl, 20 mM glutathione. Filters were probed
overnight in blocking solution supplemented with 32P-labeled GST-
(NCKSH3/SH3) ($50,000 cpm/ml), washed in blocking solution contain-
ing 0.3% bovine serum albumin, and exposed to film overnight with an
intensifying screen at 270 °C. The 59 ends of isolated clones were
sequenced using a T7–10 primer and Sequenase kit (Amersham Corp.).
The Prk2 cDNA (clone 19) was radiolabeled using [32P]dCTP and a
random primed DNA labeling kit (Boehringer Mannheim) and used to
screen the IMR90 lgt10 human fibroblast cDNA library (25). A full-
length clone was isolated and sequenced by the UNC-Chapel Hill au-
tomated DNA sequencing facility on a model 373A sequencer (Applied
Biosciences) following transposon insertion as described (26). A full-
length 3.5-kb cDNA was subcloned to pick up flanking BamHI sites and
inserted into the pZIP vector. A BamHI site was also introduced at
codon 2 of Prk2 using polymerase chain reaction, enabling it to be
cloned, in frame, into the BamHI site of the pCMV2-FLAG epitope-
tagging vector (Kodak).
Interspecific Mouse Backcross Mapping—Interspecific backcross
progeny were generated by mating (C57BL/6J 3 Mus spretus)F1 fe-
males and C57BL/6J males (27). DNA from a total of 205 N2 mice was
used to map the Prk2 locus (see text for details) by Southern blot
analysis (28). The probe, an 840-bp fragment of mouse cDNA (equiva-
lent to bp 1100–1940 of the human clone) spanning the central region
that diverges significantly from PKN, detected fragments of 16.0 and
2.3 kb in C57BL/6J DNA and fragments of 6.2 and 2.3 kb inM. spretus
DNA following digestion with HincII. The presence or absence of the
6.2-kb HincII M. spretus-specific fragment was followed in backcross
mice. A description of the probes and RFLPs for the loci linked to Prk2
has been reported (29). Recombination distances were calculated as
described (30) using the computer program SPRETUS MADNESS.
Gene order was determined by minimizing the number of recombina-
tion events required to explain the allele distribution patterns.
Miscellaneous—For Northern blot analysis, the Prk2 lEXlox c.19
cDNA was labeled as described above and used to probe a mouse tissue
poly(A)1 RNA blot (Clontech). Overnight hybridization at 42 °C in 5 3
SSC, 5 3 Denhardt’s solution, and 1% SDS plus 50% formamide was
followed by washing in 1 3 SSC, 0.2% SDS at 58 °C. The blot was then
exposed to film for 6 h with an intensifying screen. To measure binding
of GST-SH3 fusion proteins to WASP and PRK2, equal amounts of the
T7–10/WASP and T7–10/PRK2 fusion proteins isolated from the lEXlox
library (expressed from pEXlox in BL21(lysE)) were separated by SDS-
polyacrylamide gel electrophoresis, transferred to polyvinylidene diflu-
oride membrane, blocked in Tris-buffered saline-Tween, 5% nonfat milk
powder, and incubated with 20 mg of GST-fusion proteins for 3 h at room
temperature. Binding of fusion proteins was detected using anti-GST
antibody (SantaCruz Biotech), horseradish peroxidase-conjugated sec-
ondary antibody, and enhanced chemiluminescence (Amersham Corp.).
Screening of a phage-displayed random peptide library was as de-
scribed (3). Luciferase assays were performed essentially as described
(31). The serum response factor reporter plasmid contained 2 copies of
the c-fos serum response element with a mutated ternary complex
factor binding sequence (32) cloned into a luciferase reporter plasmid
that contained a minimal c-fos promoter (33).
For immunoprecipitation of PRK2, 100-mm plates of 50% confluent
COS cells were transfected with 2.5 mg of pCMV2-FLAG-Prk2 using
LipofectAMINE. After 48 h, cells were lysed in hypotonic buffer (34) and
cytosol-cleared at 14,000 3 g for 10 min. To examine GTPase binding,
NaCl and Triton X-100 were added to 100 mM and 0.05%, respectively,
and incubated with 10 mg of GST and GST-Rho, -Rac, -CDC42, or
Rap1A that were generated as described (43) and preloaded with GDP
or GTPgS by incubation with 200 mM nucleotide and 5 mM excess EDTA
for 10 min at 30 °C. GST-fusion proteins were precipitated with gluta-
thione-agarose and coprecipitation of FLAG-PRK2 determined by West-
ern blotting with M5 anti-FLAG antibody (Kodak). For kinase assays,
PRK2 was immunoprecipitated from cleared COS cell lysates using M2
anti-FLAG antibody, and the protein A/G-agarose bead-immobilized
kinase was incubated with 10 mg each of GST, GST-NCK, GST-RhoA-
GDP, or GST-GTPgS, or GST-Rac1-GTPgS for 10 min at 30 °C in the
presence of 50 mM Tris (pH 7.4), 5 mM MgCl2, 1 mM dithiothreitol,
40–100 mM protein kinase C a peptide (Pierce), 100 mM [g-32P]ATP (0.5
mCi). Reactions were terminated by spotting supernatants on Whatman
P81 filters and measuring incorporation of label into the peptide by
scintillation counting.
RESULTS AND DISCUSSION
WASP and PRK2 Bind to the SH3 Domains of NCK—Little is
known about the signaling pathways that are mediated by
NCK association with activated PTKs. Therefore, to identify
NCK binding molecules that might interact with its SH3 do-
mains to couple PTKs with novel downstream effectors, we
generated a GST-fusion protein containing the second and
third SH3 domains of NCK (codons 101–257) plus a consensus
phosphorylation site (RRASV) to facilitate labeling of the pro-
tein with [g-32P]ATP and A kinase.
The labeled probe was then used to screen a lEXlox 16-day
mouse embryo cDNA expression library. Of the unique cDNAs
isolated, one encoded the C-terminal (residues 230–502) por-
tion of the mouse homolog of the WASP (16). This sequence
contains multiple putative SH3-binding motifs (PXXP se-
quences, frequently with juxtaposed basic residues (1–3)). Blot-
ting of the WASP C terminus with GST-SH3 fusion proteins
indicated that a number of SH3 domains, including those from
FIG. 1. Binding of GST-SH3 domains to the proline-rich re-
gions of WASP and PRK2. A, a T7–10 fusion protein containing the C
terminus (codons 230–502) of the mouse Wiskott-Aldrich syndrome
protein was expressed in Escherichia coli strain BL21(lysE) from the
pEXlox bacterial expression vector. Bacterial proteins were separated
by SDS-polyacrylamide gel electrophoresis and transferred to polyvi-
nylidene fluoride membrane prior to incubation with 20 mg of the
indicated GST-SH3 proteins. Binding of SH3 domains to WASP was
detected using anti-GST antibody. The WASP C terminus bound to the
SH3 domains of NCK, Src, Grb2, phospholipase Cg, and (very weakly)
Abl but not to the other indicated SH3 domains or to GST. B, a T7–10
fusion protein containing codons 555–706 of mouse PRK2 was ex-
pressed and blotted as described above. The PRK2 fragment bound to
the middle SH3 domain of NCK and weakly to the SH3 domain of rat
phospholipase Cg but not to the other SH3 domains tested.
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Src, Grb2, phospholipase Cg and (very weakly) Abl as well as
the 3rd SH3 domain of NCK interact with WASP in vitro (Fig.
1A). A similar observation has recently been made by Rivero-
Lezcano et al. (35). Thus, WASP may be a site of convergence
for signaling from multiple SH3-containing proteins. The T
cells of WASP patients have been reported to exhibit cell sur-
face defects consistent with cytoskeletal abnormalities (36). It
is therefore not surprising that WASP has recently been found
to associate with the Rho family GTPase, CDC42, that regu-
lates the actin skeleton associated with cell surface projections/
filopodia (22, 37).
A second clone derived from our library screen shares signif-
icant homology with the catalytic domain of protein kinase C.
Using this 500-bp cDNA as a probe to screen a human fibro-
blast cDNA library (25) we isolated a full-length clone encoding
a 984-amino acid protein kinase. This protein is .99% identical
to PRK2 (18) and shares considerable identity with PRK1/
PKN, a lipid-regulated serine/threonine kinase (17, 18) that
has recently been demonstrated to bind to and be activated by
Rho-GTP (19, 20).
Northern analysis of adult mouse tissue mRNA using the
original 500-bp clone (encoding mouse PRK2 residues 555–706)
as a probe indicated that like NCK, PRK2 is ubiquitously
expressed. A ;6-kb message was present in all tissues with a
smaller less abundant message being expressed most strongly
in testis (Fig. 2A). In contrast, WASP is only expressed in cells
of hematopoietic origin (16). To determine the mouse chromo-
somal location of Prk2, interspecific backcross analysis using
progeny derived from matings of [(C57BL/6J 3 M. spretus)F1 3
C57BL/6J] mice was performed (27). C57BL/6J and M. spretus
DNAs were digested with several enzymes and analyzed by
Southern blot hybridization for informative RFLPs using a
mouse cDNA Prk2 probe. The 6.2-kb HincII M. spretus RFLP
(see “Materials and Methods”) was used to follow the segrega-
tion of the Prk2 locus in backcross mice to the distal region of
mouse chromosome 3, 5.2 cm distal of Nfkb1 and 8.2 cm prox-
imal of Rpe65 (Fig. 2B). Several genetic defects in mice map
close to this site (38, 39), and it will be of interest to determine
if they are due to PRK2 mutation. The distal region of mouse
chromosome 3 shares regions of homology with human chro-
mosomes 4q and 1p (summarized in Fig. 2B), suggesting that
Prk2 will reside on 4q or 1p, as well.
Based on the sequence of the initial 500-bp cDNA isolate
(encoding residues 555–706), the NCK-binding motif of PRK2
was predicted to reside within a unique proline-rich motif,
located just N-terminal to the kinase domain that is absent
from PKN. Consistently, using a phage-displayed random pep-
tide library containing the sequence X6PXXPX6 (3) we deter-
mined the consensus binding sequence for the second NCK SH3
domain to be very similar to the putative NCK-binding domain
of PRK2 (Table I). Furthermore, only this second SH3 domain
of NCK specifically bound to the residues 555–706 PRK2 frag-
ment (Fig. 1B). While PRK2 weakly interacted with the SH3
domain of phospholipase Cg, it did not bind to the SH3 domains
of other adaptor molecules, protein kinases, cytoskeletal pro-
teins (cortactin, fodrin),2 neutrophil NADPH oxidase p67, or
p120 Ras-GAP, suggesting a specific role for PRK2 in NCK-
mediated signaling.
NCK May Couple PTK Signaling to Rho-activated Path-
ways—In addition to WASP and PRK2, NCK has also been
reported to bind to the p21 Rac- and CDC42-activated kinase,
PAK3 (21).3 Indeed, the N-terminal sequences of PAKs share
considerable homology with the NCK SH3-binding sequences
of PRK2, including a negatively charged sequence N-terminal
to the PXXP motif (Table I). These findings suggested that
NCK mediates signal transduction from activated PTKs to
the Rho family (Rho, Rac, and CDC42) of GTPases that reg-
ulate cytoskeletal and/or transcriptional events via multiple
effectors.
The PRK2-related kinase, PKN, is activated following asso-
ciation of an a-helical N-terminal domain (located between
residues 34 and 103 of PKN) with Rho-GTP (19). Since this
region of PKN is well conserved (53% identity, 84% homology)
with PRK2, we investigated whether it too might interact with
Rho family GTPases. As shown in Fig. 3, incubation of GST-
fusion proteins of RhoA, Rac1, and CDC42 or the Ras-related
Rap1A with cytosol from COS cells transiently overexpressing
recombinant PRK2 resulted in the specific association of RhoA
FIG. 2. Tissue and chromosomal localization of mouse Prk2. A,
Prk2 message is ubiquitously expressed. A mouse multitissue poly(A)1
RNA Northern blot (Clontech) was probed with a random-primed Prk2
fragment consisting of bases 690-1507 of the mouse cDNA as described
under “Materials and Methods.” A message of ;6 kb was detected in all
tissues with a smaller (,4 kb) message being most abundant in testis.
B, Prk2 maps in the distal region of mouse chromosome 3. Prk2 was
placed on mouse chromosome 3 by interspecific backcross analysis. The
segregation patterns of Prk2 and flanking genes in 139 backcross ani-
mals that were typed for all loci are shown at the top of the figure. For
individual pairs of loci, more than 139 animals were typed. Each col-
umn represents the chromosome identified in the backcross progeny
that was inherited from the (C57BL/6J 3 M. spretus)F1 parent. The
black boxes represent the presence of a C57BL/6J allele, andwhite boxes
represent the presence of a M. spretus allele. The number of offspring
inheriting each type of chromosome is listed at the bottom of each
column. A partial chromosome 3 linkage map showing the location of
Prk2 in relation to linked genes is shown at the bottom of the figure. The
number of recombinant N2 animals is presented over the total number
of N2 animals typed, to the left of the chromosome map. The recombi-
nation frequencies, expressed as genetic distance in centimorgans (61
S.E.), are also shown. The positions of loci in human chromosomes,
where known, are shown to the right. References for the human map
positions of loci cited in this study can be obtained from GDB (Genome
Data Base), a computerized data base of human linkage information
maintained by The William H. Welch Medical Library of The Johns
Hopkins University (Baltimore, MD).
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with PRK2 in a GTP-dependent manner. Thus, similarly to
PKN, PRK2 is likely to be a Rho protein effector. In contrast to
studies on PKN where GST-Rho-GTPgS was shown to activate
its kinase activity 2–6-fold in vitro (19, 20), we did not observe
any significant effect of Rho or Rac on the ability of FLAG-
PRK2 to phosphorylate itself or a protein kinase C a pseudo-
substrate peptide.2 This may have been due to the presence of
the epitope tag, which was required to immunoprecipitate the
enzyme from cell lysates, constitutively activating the kinase.
Indeed a similar problem was also recently encountered upon
epitope-tagging PAK1 (40).
Rho family proteins have been reported to induce transcrip-
tional activation from the c-fos serum response element via the
serum response factor (SRF) (32). However, the downstream
effector(s) of Rho that mediates SRF activation has yet to be
identified. To determine if PRK2 might mediate Rho protein-
induced transcriptional activation we looked at its ability to
cooperate with Rho family GTPases to induce gene expression
from the c-fos serum response element. PRK2 induced tran-
scriptional activation from a SRF-luciferase reporter construct
and cooperated with the Rho family GTPases RhoA and CDC42
(Fig. 4) as well as Rac1 and the Rho family guanine nucleotide
exchange factor, Dbl.2 Since PRK2 specifically interacts with
Rho versus Rac and CDC42 it was surprising to find that it
cooperates with multiple Rho family proteins. However, this
activity may reflect the fact that Rho is located downstream of
Rac and CDC42 in signal transduction pathways (reviewed in
Ref. 41).
Transcriptional activation induced by the GTP-bound forms
of the Ras and Rac GTPases is believed to be mediated by
interaction with the serine/threonine protein kinases Raf and
PAK, respectively, resulting in activation of mitogen-activated
protein kinase cascades (4, 41). Therefore, PRK2 and PKNmay
similarly activate a related cascade(s) upon Rho-GTP binding
that results in SRF activation. There is a precedent for such a
pathway in Saccharomyces cerevisiae, where binding of Rho-
GTP to PKC1 leads to activation of a mitogen-activated protein
kinase cascade via BCK, MKK, and MPK to induce cell wall
biosynthesis (42). Since the catalytic domains of PRK2 and
PKN show strong identity with those of protein kinases C, they
may represent functional mammalian homologs of the yeast
PKC1. While PRK2 and PKN share significant identity, the
ability of PRK2 to bind to NCK may promote differential reg-
ulation and/or subcellular localization of these two kinases.
Indeed, unlike GST or GST-Rho-GTPgS, GST-NCK inhibited
the ability of PRK2 to phosphorylate the PKCa pseudosub-
strate peptide by 47.4 6 10.0% (mean 6 S.E., from four inde-
pendent experiments). However, as noted above, FLAG-PRK2
kinase activity may have been artificially elevated by its
epitope tag. Similarly to Grb2-mediated regulation of Sos (4),
the role of NCK may be to target effectors such as PRK2,
WASP, and PAK to sites of PTK activation, e.g. plasma mem-
brane or focal adhesion complexes. Alternatively, the kinase
experiments indicate that NCK may also be a negative regula-
tor of PRK2 function.
Although it is becoming apparent that Rho family GTPases,
and their subsequent induction of transcriptional activation via
Jun NH2-terminal kinase/stress-activated protein kinase and
SRF, are important downstream components of many cellular
signaling pathways (41), little is known about how extracellu-
lar stimuli modulate Rho protein function. Our observation
that NCK, which associates with activated PTKs, can bind to
two putative Rho protein effectors suggests that NCK acts as
an adapter to connect receptor-mediated events to Rho protein
signaling. Taken together with the previous observation that
NCK also binds to PAKs (21),3 these data suggest that NCK
may modulate multiple Rho protein-mediated signaling events.
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